Immunization, Vaccines and Biologicals
The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy.
Costing, Financing and Supply of HPV vaccine
Economic and financial issues can be barriers to HPV vaccine introduction. WHO has created a number of analytical decision-making tools to assist countries with the introduction and scaling up of HPV vaccination programmes and cervical cancer screening and treatment.
The tools on this page can be used in setting priorities for programming, financial planning and sustainability.
The tools on this page can be used in setting priorities for programming, financial planning and sustainability.
Costing
- Costing HPV vaccination delivery with other health interventions for adolescents : the Adolescent health Module in the OneHealth Tool
- WHO Cervical Cancer Prevention and Control Costing Tool (C4P)
- Online course of WHO Cervical Cancer Prevention and Control Costing Tool: HPV vaccination
- PRIME Tool, a modelling tool for assessing the economic and human impact of vaccination against human papillomavirus
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study (2014)
- HPV vaccine introduction in low and middle income countries: guidance on the use of CE models (2011)
Financing & Supply
Resources
HPV introduction - technical resources
This toolbox on the TechNet-21 website contains practical tools often developed by EPI programmes and partners and is regularly updated.
